Boussard & Gavaudan Investment Management LLP Bio Rad Laboratories, Inc. Transaction History

Boussard & Gavaudan Investment Management LLP

$121 Million
Q1 2025

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Jan 15, 2019	SELL	$220.1 - $309.0 $142,624 - $200,232	-648 Closed	0 $0
Q3 2018 Oct 04, 2018	BUY	$289.28 - $326.15 $187,453 - $211,345	648 New	648 $202,000

Others Institutions Holding BIO

# of Institutions

463

Shares Held

18.9M

Call Options Held

12.7K

Put Options Held

14.4K

Vanguard Group Inc Valley Forge, PA

1.91M
Shares

$453 Million
0.01% of portfolio
First Eagle Investment Management, LLC

1.57M
Shares

$371 Million
0.8% of portfolio
Black Rock Inc. New York, NY

1.55M
Shares

$367 Million
0.01% of portfolio
Veritas Asset Management LLP

913K
Shares

$216 Million
2.52% of portfolio
Dimensional Fund Advisors LP Austin, TX

877K
Shares

$208 Million
0.05% of portfolio

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $5.83B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boussard & Gavaudan Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Boussard & Gavaudan Investment Management LLP with notifications on news.

Account